The University of Iowa Campus

Resources For...

Faculty & Staff                              Students                                  Community

Welcome

The Human Subjects Office (HSO) was established by the Vice President for Research to provide administrative support for the University of Iowa Institutional Review Boards. An Institutional Review Board is a group of individuals charged with reviewing proposed research involving human subjects to ensure the protection of those subjects and compliance with federal human subjects regulations. The University of Iowa has three such review boards, each consisting of faculty, staff, and representatives from the Iowa City community.

Mission

The mission of the University of Iowa Institutional Review Boards is to assure that the rights and welfare of human subjects are adequately protected in research.

Upcoming Events

Wed, Aug 27, 2014 - 2:00pm to 4:00pm

Office Hours - Location: 101 Hardin Library

Wed, Sep 03, 2014 - 2:00pm to 4:00pm

Office Hours - Location: 101 Hardin Library

Fri, Sep 05, 2014 - 9:00am to 11:30am

How to Complete a New Project Application - Location: Hardin Library Information Commons EAST

Upcoming Meetings

Thu, Aug 21, 2014 - 2:00pm to 5:00pm

IRB-01 Full Board Meeting - Location: 101 HLHS

Wed, Aug 27, 2014 - 9:00am to 12:00pm

IRB 02 Full Board Meeting - Location: 101 HLHS

Announcements

FDA Final Guidance on Evaluation of Sex-Specific Data in Medical Device Clinical Studies

The Food and Drug Administration (FDA) has recently issued a final guidance document on the Evaluation of Sex-Specific Data in Medical Device Clinical Studies, in combination with

FDA Final Guidance for Investigational Device Exemptions (IDE) Clinical Investigations

The Food and Drug Administration (FDA) has recently issued a final guidance document on

IRB Updates - Changes to P&T and P&T IDS approval process

Changes to the Pharmacy & Therapeutics (P&T) Review and Approval of Human Subjects Research Effective immediately, any IRB-01 or IRB-03 researchers conducting human subjects research requiring P&T approval needs to be aware that the Pharmacy & Therapeutics Committee and the Pharmacy & Therapeutics Investigational Drug Service (IDS) reviews have now been split.  P&T and P&T IDS will be recognized as two separate committee reviews in the HawkIRB application system.  

Live webcast of the Secretary’s Advisory Committee for Human Research Protections (SACHRP)

The July 21-22 2014 meeting of the Secretary’s Advisory Committee for Human Research Protections (SACHRP) will be webcast live at http://videocast.nih.gov. For the SACHRP agenda, go to: http://www.hhs.gov/ohrp/sachrp/mtgings/2014%20Jul%20Mtg/july21-22,2014sachrpmeeting.html.